SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

Stealth BioTherapeutics Q3 EPS $(0.04), Inline

Stealth BioTherapeutics (NASDAQ:MITO) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate.

Benzinga · -

Stealth BioTherapeutics (NASDAQ:MITO) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate.